Pertussis
| aka whooping cough | |
|---|---|
| Etiology | Bordetella pertussis, despite sounding like a cheese, is a gram negative coccobacillus. |
| Epidemiology | Incomplete immunisation = ↑↑ risk |
| Pathogenesis | Virulence factors: - fimbriae - exotoxin → thickened bronchial secretions, paralysis of cilia |
| Clinical presentation | - Incubation 7-10 days - 1-2 weeks nonspecific symptoms → classic cough +/- vomiting after coughing fits ➥ infants more likely to show atypical s/s: apnoea, difficulty feeding ➥ Cough can last 2-3 months (100-day cough) Higher risk if incomplete immunisation |
| Investigations | Nasopharyngeal swab If symptoms present >2/52, pertussis IgG serology can be used if age >17 FBC: lymphocytosis |
| Management | Symptomatic management - Macrolides - only really effective if established before paroxysms Antibiotics do not alter the clinical course once the disease is established - Considered noninfectious after 3/52 hence no abx after 3/52 symptoms - or 14 days according to CKS... HIGHLY infectious, R0 = 15-17 Complications: apnoeas, cyanosis |
Prescribing
- Prescribe a macrolide first line:
- For infants aged under 1 month, clarithromycin is preferred. Azithromycin may be used although there are limited data in this age group.
- For children aged over 1 year, prescribe azithromycin or clarithromycin.
- For non-pregnant adults, prescribe azithromycin or clarithromycin.
- For pregnant women, prescribe erythromycin. The second line option is azithromycin and third line clarithromycin, as alternatives where necessary.
- If macrolides are contraindicated or not tolerated, prescribe co-trimoxazole.
- Do not prescribe co-trimoxazole to pregnant women or infants younger than six weeks old.
role of abx
- microbiological eradication
- no difference in mortality
- Applies to:
- Children
- staff working with children including school and healthcare workers
- stay out from school until:
- 48h on appropriate abx
- 21 days from onset of coughing if no abx and well enough to return
- avoid contact with infants under one year who are unvaccinated, partially vaccinated, or pregnant women
Post-exposure
Vaccination
Catch up on any missed vax
Booster if last dose >5y ago
Prophylaxis:
- is for:
- those at ↑ risk complications, or
- ↑ risk transmission
- macrolide 1st line = clarithromycin/azithromycin; erythromycin in pregnant patients; co-trimoxazole if macrolides contraindicated
Vaccine uptake 92.9% of 2yos in 2023 vs 96.3% in 2014
- Vaccination of pregnant patients
- Very contagious!
- Notifiable disease
vaccination
| Time frame | Vaccine |
|---|---|
| 2 months | DTaP/IPV/Hib |
| 3 months | DTaP/IPV/Hib |
| 4 months | DTaP/IPV/Hib |
| Preschool | DTaP/IPV |
- also offered in pregnancy → ↓ risk of infant death from pertussis by 92%!
external links
https://www.rcemlearning.co.uk/modules/rcemlearning-blog-pertussis/exams/rcemlearning-blog-pertussis/
https://dontforgetthebubbles.com/pertussis/
https://dontforgetthebubbles.com/the-resurgence-of-vaccine-preventable-infections-measles-and-pertussis/ (sigh)
https://cks.nice.org.uk/topics/whooping-cough/management/management-of-whooping-cough/